Yuhan Corp. (000100) - Total Liabilities
Based on the latest financial reports, Yuhan Corp. (000100) has total liabilities worth ₩858.64 Billion KRW (≈ $581.89 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Yuhan Corp. net asset momentum to track the company's year-over-year net asset growth rate.
Yuhan Corp. - Total Liabilities Trend (2000–2025)
This chart illustrates how Yuhan Corp.'s total liabilities have evolved over time, based on quarterly financial data. See 000100 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Yuhan Corp. Competitors by Total Liabilities
The table below lists competitors of Yuhan Corp. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hilton Grand Vacations Inc
NYSE:HGV
|
USA | $10.59 Billion |
|
Dajin Heavy Industry Corp
SHE:002487
|
China | CN¥6.18 Billion |
|
Escorts Kubota Limited
NSE:ESCORTS
|
India | Rs31.83 Billion |
|
Levima Advanced Materials Corp
SHE:003022
|
China | CN¥17.85 Billion |
|
Mirion Technologies Inc
NYSE:MIR
|
USA | $1.65 Billion |
|
Shanxi Coal International Energy Group Co Ltd
SHG:600546
|
China | CN¥19.75 Billion |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521
|
China | CN¥12.36 Billion |
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
USA | $357.16 Million |
Liability Composition Analysis (2000–2025)
This chart breaks down Yuhan Corp.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Yuhan Corp. market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Yuhan Corp.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Yuhan Corp. (2000–2025)
The table below shows the annual total liabilities of Yuhan Corp. from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩858.64 Billion ≈ $581.89 Million |
+8.50% |
| 2024-12-31 | ₩791.38 Billion ≈ $536.31 Million |
+11.20% |
| 2023-12-31 | ₩711.65 Billion ≈ $482.27 Million |
+53.07% |
| 2022-12-31 | ₩464.92 Billion ≈ $315.07 Million |
-11.93% |
| 2021-12-31 | ₩527.92 Billion ≈ $357.77 Million |
-3.49% |
| 2020-12-31 | ₩547.02 Billion ≈ $370.71 Million |
+17.08% |
| 2019-12-31 | ₩467.21 Billion ≈ $316.62 Million |
-10.51% |
| 2018-12-31 | ₩522.08 Billion ≈ $353.80 Million |
+6.91% |
| 2017-12-31 | ₩488.35 Billion ≈ $330.95 Million |
-11.11% |
| 2016-12-31 | ₩549.39 Billion ≈ $372.31 Million |
+6.39% |
| 2015-12-31 | ₩516.39 Billion ≈ $349.95 Million |
+51.83% |
| 2014-12-31 | ₩340.11 Billion ≈ $230.49 Million |
+19.03% |
| 2013-12-31 | ₩285.72 Billion ≈ $193.63 Million |
+32.98% |
| 2012-12-31 | ₩214.87 Billion ≈ $145.61 Million |
+8.88% |
| 2011-12-31 | ₩197.34 Billion ≈ $133.74 Million |
+7.96% |
| 2010-12-31 | ₩182.79 Billion ≈ $123.87 Million |
+9.40% |
| 2009-12-31 | ₩167.09 Billion ≈ $113.23 Million |
-5.22% |
| 2008-12-31 | ₩176.29 Billion ≈ $119.47 Million |
-26.77% |
| 2007-12-31 | ₩240.74 Billion ≈ $163.15 Million |
-10.50% |
| 2006-12-31 | ₩268.99 Billion ≈ $182.29 Million |
-12.04% |
| 2005-12-31 | ₩305.81 Billion ≈ $207.24 Million |
+24.37% |
| 2004-12-31 | ₩245.88 Billion ≈ $166.63 Million |
+24.47% |
| 2003-12-31 | ₩197.55 Billion ≈ $133.87 Million |
-11.46% |
| 2002-12-31 | ₩223.10 Billion ≈ $151.19 Million |
+4.10% |
| 2001-12-31 | ₩214.31 Billion ≈ $145.24 Million |
-7.84% |
| 2000-12-31 | ₩232.55 Billion ≈ $157.60 Million |
-- |
About Yuhan Corp.
Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and ana… Read more